Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer

The ability to develop a comprehensive panel of treatment predicting factors would significantly improve our ability to stratify patients for cytotoxic or targeted therapies, and prevent patients receiving ineffective treatments. We have investigated if a recently developed genome-wide haploid genet...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yuk Ting, Leonard, Sarah M., Gordon, Naheema, Anderton, Jennifer, James, Claire, Huen, David, Woodman, Ciaran B., Palmer, Daniel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609949/
https://www.ncbi.nlm.nih.gov/pubmed/28969017
http://dx.doi.org/10.18632/oncotarget.18879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609949/
https://www.ncbi.nlm.nih.gov/pubmed/28969017
http://dx.doi.org/10.18632/oncotarget.18879

Ejemplares similares